L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Tonix Pharmaceuticals Holding Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:05 pm Sale | 2024-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -4,322 (Position Closed) | Filing |
| 2024-06-20 4:01 pm Purchase | 2024-06-12 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | L1 Capital Global Opportunities Master Fund, Ltd. | 4,322 9.990% | 4,322 (New Position) | Filing |